Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating the combination of samarium-153 lexidronam pentasodium and high-dose melphalan in patients with multiple myeloma under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (brand Alkeran) (melphalan)
• Quadramet (samarium-153 lexidronam pentasodium) (samarium-153 lexidronam pentasodium)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 1, Phase 2 | Status: COMPLETED